|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV053145658 |
| 003 |
DE-627 |
| 005 |
20230624192424.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
210910s2021 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.earlhumdev.2020.105304
|2 doi
|
| 028 |
5 |
2 |
|a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001319.pica
|
| 035 |
|
|
|a (DE-627)ELV053145658
|
| 035 |
|
|
|a (ELSEVIER)S0378-3782(20)30808-2
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 084 |
|
|
|a 44.45
|2 bkl
|
| 100 |
1 |
|
|a Örtqvist, Maria
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Movements and posture in infants born extremely preterm in comparison to term-born controls
|
| 264 |
|
1 |
|c 2021
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a Identifying altered motor development at an early stage is crucial for infants born extremely preterm (EPT), as they face a high risk of long-term neurodevelopmental impairment. The Prechtl General Movement Assessment (GMA), including the Motor Optimality Score Revised (MOS-R), can provide important insights into these infants' later neurodevelopmental function.
|
| 700 |
1 |
|
|a Einspieler, Christa
|4 oth
|
| 700 |
1 |
|
|a Marschik, Peter B.
|4 oth
|
| 700 |
1 |
|
|a Ådén, Ulrika
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
| 773 |
1 |
8 |
|g volume:154
|g year:2021
|g pages:0
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2020.105304
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 154
|j 2021
|h 0
|